Friederike Pfisterer

658 total citations
6 papers, 76 citations indexed

About

Friederike Pfisterer is a scholar working on Clinical Biochemistry, Aging and Nephrology. According to data from OpenAlex, Friederike Pfisterer has authored 6 papers receiving a total of 76 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Clinical Biochemistry, 3 papers in Aging and 2 papers in Nephrology. Recurrent topics in Friederike Pfisterer's work include Advanced Glycation End Products research (4 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and Dialysis and Renal Disease Management (2 papers). Friederike Pfisterer is often cited by papers focused on Advanced Glycation End Products research (4 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers) and Dialysis and Renal Disease Management (2 papers). Friederike Pfisterer collaborates with scholars based in Germany and Luxembourg. Friederike Pfisterer's co-authors include Vedat Schwenger, Angelika Bierhaus, Michael Morcos, Christian Morath, M.-L. Gross, Peter P. Nawroth, Andrea Schlotterer, G Kukudov, A. Hamann and Martin Zeier and has published in prestigious journals such as Nephrology Dialysis Transplantation, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology and Hormone and Metabolic Research.

In The Last Decade

Friederike Pfisterer

6 papers receiving 74 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friederike Pfisterer Germany 4 29 27 25 17 11 6 76
Evgeny Farber Israel 7 13 0.4× 22 0.8× 7 0.3× 16 0.9× 15 1.4× 14 89
Kaifeng Wei China 5 9 0.3× 22 0.8× 14 0.6× 11 0.6× 63 5.7× 8 140
Cijang He United Kingdom 2 30 1.0× 16 0.6× 63 2.5× 9 0.5× 20 1.8× 2 99
Tomasz Urasiński Poland 5 8 0.3× 24 0.9× 8 0.3× 5 0.3× 10 0.9× 8 78
Guixia Wang China 3 38 1.3× 54 2.0× 10 0.4× 18 1.1× 26 2.4× 6 134
Arianna Durante Italy 6 69 2.4× 12 0.4× 68 2.7× 38 2.2× 29 2.6× 8 127
Jenny Söderlund Finland 6 102 3.5× 16 0.6× 84 3.4× 27 1.6× 18 1.6× 7 159
Koichi Asahi Japan 4 12 0.4× 38 1.4× 21 0.8× 3 0.2× 8 0.7× 8 121
H Rudzki Poland 4 26 0.9× 30 1.1× 6 0.2× 11 0.6× 10 0.9× 8 72
Hideo Machimura Japan 5 29 1.0× 11 0.4× 6 0.2× 8 0.5× 8 0.7× 11 52

Countries citing papers authored by Friederike Pfisterer

Since Specialization
Citations

This map shows the geographic impact of Friederike Pfisterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Pfisterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Pfisterer more than expected).

Fields of papers citing papers by Friederike Pfisterer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friederike Pfisterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Pfisterer. The network helps show where Friederike Pfisterer may publish in the future.

Co-authorship network of co-authors of Friederike Pfisterer

This figure shows the co-authorship network connecting the top 25 collaborators of Friederike Pfisterer. A scholar is included among the top collaborators of Friederike Pfisterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friederike Pfisterer. Friederike Pfisterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Schlotterer, Andrea, Friederike Pfisterer, G Kukudov, et al.. (2018). Neuronal damage and shortening of lifespan in C.�elegans by peritoneal dialysis fluid: Protection by glyoxalase‑1. Biomedical Reports. 8(6). 540–546. 4 indexed citations
2.
Schlotterer, Andreas, G Kukudov, Farastuk Bozorgmehr, et al.. (2009). C. elegans as model for the study of high glucose mediated lifespan reduction Running title: Glucose regulates lifespan in C. elegans. 1 indexed citations
3.
Morcos, Michael, Andrea Schlotterer, G Kukudov, et al.. (2008). Rosiglitazone Reduces Angiotensin II and Advanced Glycation End Product-dependent Sustained Nuclear Factor-κB Activation in Cultured Human Proximal Tubular Epithelial Cells. Hormone and Metabolic Research. 40(11). 752–759. 25 indexed citations
4.
Kihm, Lars, Friederike Pfisterer, Christian Morath, et al.. (2008). RAGE expression in the human peritoneal membrane. Nephrology Dialysis Transplantation. 23(10). 3302–3306. 28 indexed citations
5.
Morcos, Michael, Berthold Fohr, Friederike Pfisterer, et al.. (2007). Long-Term Treatment of Central Cushing's Syndrome with Rosiglitazone. Experimental and Clinical Endocrinology & Diabetes. 115(5). 292–297. 17 indexed citations
6.
Du, Ximing, Ahmed M. Sayed, Harald Hutter, et al.. (2007). Life extension in Caenorhabditis elegans by overexpression of Glyoxalase I — A mechanistic integration of protein damage by glycation, oxidation and nitratio. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 146(4). S59–S59. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026